Finepoint Capital LP
- SEC CIK
- 0001608126
- 最新申報
- 2026/8/13
2023 年第 3 季持倉
持倉截至 2023/9/30，2023/11/13 申報。只含多頭部位，變化是跟 2023 年第 2 季比股數。
- 持股檔數
- 30
- 較 2023 年第 2 季 −7
- 總值
- $2.01 億
- 較 2023 年第 2 季 −$8,827 萬 (−30.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 331,416 | $1,889 萬 | 9.4% | +29,416+9.7% | 加碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 1,489,025 | $1,811 萬 | 9.0% | +163,250+12.3% | 加碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 145,357 | $1,762 萬 | 8.8% | +19,900+15.9% | 加碼 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 349,300 | $1,685 萬 | 8.4% | +32,000+10.1% | 加碼 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 458,659 | $1,585 萬 | 7.9% | +51,800+12.7% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 163,772 | $1,534 萬 | 7.6% | +24,000+17.2% | 加碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 556,928 | $1,288 萬 | 6.4% | −51,700−8.5% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 431,693 | $1,272 萬 | 6.3% | +62,600+17.0% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 563,345 | $1,230 萬 | 6.1% | +70,800+14.4% | 加碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 427,000 | $1,182 萬 | 5.9% | +427,000 | 新進 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 556,553 | $1,160 萬 | 5.8% | −290,400−34.3% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 504,700 | $991.2 萬 | 4.9% | +93,200+22.6% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 895,821 | $800.9 萬 | 4.0% | +134,100+17.6% | 加碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 325,356 | $745.4 萬 | 3.7% | +37,800+13.1% | 加碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 870,870 | $732.4 萬 | 3.6% | +169,300+24.1% | 加碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM NEW | 961,251 | $242.2 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| CLDICalidi Biotherapeutics, Inc. | CL A | 125,000 | $41.6 萬 | 0.2% | +125,000 | 新進 | 歷史 |
| Ares Acquisition CorporationG33032122 | *W EXP 99/99/999 | 504,706 | $33.4 萬 | 0.2% | 00.0% | 不變 | – |
| Bridgetown Holdings LtdG1355U121 | *W EXP 09/30/202 | 895,000 | $30.4 萬 | 0.2% | 00.0% | 不變 | – |
| Churchill Capital Corp VII17144M110 | *W EXP 02/29/202 | 548,000 | $16.9 萬 | 0.1% | 00.0% | 不變 | – |
| CLDWWCalidi Biotherapeutics, Inc. | *W EXP 03/14/202 | 655,200 | $14.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Compass Digital Acquisitn CoG2476C123 | *W EXP 09/29/202 | 459,906 | $10.1 萬 | 0.1% | 00.0% | 不變 | – |
| Churchill Capital Corp VI17143W119 | *W EXP 02/17/202 | 540,000 | $8.64 萬 | <0.1% | 00.0% | 不變 | – |
| Ross Acquisition Corp IIG7641C114 | *W EXP 02/01/202 | 439,666 | $4.90 萬 | <0.1% | 00.0% | 不變 | – |
| CNDAWConcord Acquisition Corp II | *W EXP 99/99/999 | 408,333 | $4.26 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Swiftmerge Acquisition CorpG63836111 | *W EXP 12/13/202 | 490,000 | $3.46 萬 | <0.1% | 00.0% | 不變 | – |
| Ys Biopharma Co LtdG9845F117 | *W EXP 03/15/202 | 489,999 | $1.72 萬 | <0.1% | 00.0% | 不變 | – |
| Marblegate Acquisition Corp.56608A113 | *W EXP 08/31/202 | 735,000 | $1.35 萬 | <0.1% | 00.0% | 不變 | – |
| Churchill Capital Corp V17144T115 | *W EXP 10/29/202 | 612,000 | $0 | 0.0% | 00.0% | 不變 | – |
| Home Plate Acquisition Corp43734R111 | *W EXP 09/30/202 | 690,000 | $0 | 0.0% | 00.0% | 不變 | – |
2023 年第 2 季之後清倉（9 檔）
2023 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 2 季股數 | 2023 年第 2 季市值 | 2023 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 241,690 | $2,202 萬 | 7.6% | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 357,765 | $1,682 萬 | 5.8% | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 797,527 | $1,437 萬 | 5.0% | 歷史 |
| CLVTClarivate PLC | ORD SHS | 1,247,406 | $1,189 萬 | 4.1% | 歷史 |
| BHCBausch Health Companies Inc. | Stock | 1,165,000 | $932.0 萬 | 3.2% | 歷史 |
| Afternext Healthtech AcquisiG01109126 | *W EXP 99/99/999 | 366,666 | $3.18 萬 | <0.1% | – |
| Conyers Park III Acqsitn Cor21289P110 | *W EXP 08/12/202 | 571,666 | $2.86 萬 | <0.1% | – |
| Bilander Acquisition Corp.09001T114 | *W EXP 05/19/202 | 183,749 | $9,334 | <0.1% | – |
| Corsair Partnering CorpG2540H116 | *W EXP 07/06/202 | 334,666 | $0 | 0.0% | – |